Get the Stockscreener App
1.93
0.52%
0.01
After Hours:
1.91
-0.02
-1.04%
Essa Pharma Inc stock is traded at $1.93, with a volume of 640.43K.
It is up +0.52% in the last 24 hours and up +3.76% over the past month.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
See More
Previous Close:
$1.92
Open:
$1.92
24h Volume:
640.43K
Relative Volume:
2.49
Market Cap:
$91.31M
Revenue:
-
Net Income/Loss:
$-28.54M
P/E Ratio:
-3.0156
EPS:
-0.64
Net Cash Flow:
$-22.72M
1W Performance:
+0.00%
1M Performance:
+3.76%
6M Performance:
+12.21%
1Y Performance:
-64.19%
1-Day Range:
$1.92
$1.94
1-Week Range:
$1.91
$1.94
52-Week Range:
$1.40
$7.88
Essa Pharma Inc Stock (EPIX) Company Profile
Name
Essa Pharma Inc
Sector
Industry
Phone
(778) 331-0962
Address
SUITE 720, VANCOUVER, BC
Compare EPIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EPIX
Essa Pharma Inc
|
1.93 | 90.36M | 0 | -28.54M | -22.72M | -0.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-04-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-04-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jun-26-23 | Resumed | Oppenheimer | Outperform |
| Mar-04-21 | Initiated | Piper Sandler | Overweight |
| Jan-11-21 | Reiterated | H.C. Wainwright | Buy |
| Nov-02-20 | Initiated | Jefferies | Buy |
| Oct-25-19 | Initiated | Oppenheimer | Outperform |
View All
Essa Pharma Inc Stock (EPIX) Latest News
Identifying reversal signals in ESSA Pharma Inc.Market Performance Recap & Reliable Breakout Forecasts - Newser
Will ESSA Pharma Inc. outperform the marketPortfolio Value Summary & Weekly Setup with High ROI Potential - Newser
Short interest data insights for ESSA Pharma Inc.Dividend Hike & Consistent Profit Trading Strategies - Newser
How to build a custom watchlist for ESSA Pharma Inc.Dividend Hike & Free Accurate Trade Setup Notifications - Newser
ESSA Pharma Announces Tax Implications of Cash Distribution - MSN
What makes ESSA Pharma Inc. stock price move sharplyJuly 2025 News Drivers & Safe Swing Trade Setup Alerts - Newser
Quantitative breakdown of ESSA Pharma Inc. recent movePortfolio Value Summary & Stepwise Swing Trade Plans - Newser
Is ESSA Pharma Inc. reversing from oversold territoryJuly 2025 Opening Moves & Community Driven Trade Alerts - Newser
ESSA Pharma Reports Q2 Loss Amid Strategic Transition - TipRanks
Can ESSA Pharma Inc. hit a new high this monthWeekly Risk Report & Consistent Income Trade Recommendations - Newser
What candlestick patterns are forming on ESSA Pharma Inc.Gap Up & Breakout Confirmation Trade Signals - Newser
Visualizing ESSA Pharma Inc. stock with heatmaps2025 Earnings Surprises & Community Consensus Trade Alerts - Newser
XTX Topco Ltd Reduces Holdings in ESSA Pharma Inc. (NASDAQ:EPIX) - Defense World
Chart based analysis of ESSA Pharma Inc. trendsMarket Risk Analysis & Smart Allocation Stock Reports - Newser
Will ESSA Pharma Inc. Benefit From Broader Market BounceGap Up & Short-Term High Return Ideas - metal.it
What machine learning models say about ESSA Pharma Inc.July 2025 Spike Watch & Reliable Price Action Trade Plans - Newser
Detecting price anomalies in ESSA Pharma Inc. with AIMarket Growth Summary & Precise Swing Trade Alerts - Newser
ESSA Pharma Announces $80M Cash Distribution, Ex-Dividend Date, and Nasdaq Due Bill Trading. - AInvest
ESSA Pharma Announces $80M Capital Distribution to Shareholders - AInvest
Technical analysis overview for ESSA Pharma Inc. stockJuly 2025 Setups & Accurate Trade Setup Notifications - Newser
Can ESSA Pharma Inc. Regain Lost Ground This QuarterWeekly Gains Report & Reliable Breakout Forecasts - beatles.ru
Is ESSA Pharma Inc. meeting your algorithmic filter criteriaWeekly Trend Report & AI Powered Market Entry Strategies - Newser
Can ESSA Pharma Inc. Escape Recent Bear ChannelWeekly Trading Summary & Daily Stock Trend Reports - sundaytimes.kr
Will ESSA Pharma Inc. benefit from AI trendsJobs Report & Safe Swing Trade Setup Alerts - thegnnews.com
Will ESSA Pharma Inc. benefit from macro trendsQuarterly Trade Review & Breakout Confirmation Trade Signals - Newser
ESSA Pharma Inc. stock chart pattern explainedJuly 2025 Momentum & AI Enhanced Execution Alerts - Newser
Using data tools to time your ESSA Pharma Inc. exitBear Alert & Low Risk High Win Rate Stock Picks - Newser
ESSA Pharma Announces $80M Capital Distribution - TipRanks
ESSA Pharma Shareholders to Get $1.69 Per Share as Company Prepares for XenoTherapeutics Deal - Stock Titan
ESSA Pharma: Fiscal Q3 Earnings Snapshot - Norwalk Hour
Is ESSA Pharma Inc. stock a good hedge against inflation2025 Dividend Review & Free Expert Verified Stock Movement Alerts - Newser
Essa Pharma Inc Stock (EPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Essa Pharma Inc Stock (EPIX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BIOTECH GROWTH N V | 10% Owner |
Nov 01 '24 |
Sale |
1.53 |
7,879,583 |
12,018,409 |
0 |
| Virsik Peter | Chief Operating Officer |
Oct 07 '24 |
Sale |
6.03 |
694 |
4,185 |
7,776 |
| Virsik Peter | Chief Operating Officer |
Sep 09 '24 |
Sale |
6.00 |
694 |
4,164 |
8,470 |
| Virsik Peter | Chief Operating Officer |
Sep 03 '24 |
Sale |
6.03 |
2,082 |
12,554 |
9,164 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):